XML 23 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Operating activities    
Net loss $ (348,655) $ (280,401)
Adjustments to reconcile net loss to net cash used in operating activities:    
Share-based compensation expense 202,109 235,018
Depreciation and amortization 147,967 109,007
Goodwill impairment 247,174 0
Deferred debt issuance and discount expense 15,049 12,106
Provision for credit losses 42,853 39,387
Deferred income taxes (6,333) (4,420)
Fair value changes in residual interests classified as debt 414 7,078
Fair value changes in securitization investments 1,067 13,256
Other (2,613) 11,635
Changes in operating assets and liabilities:    
Changes in loans held for sale, net (7,315,543) (4,971,084)
Servicing assets 6,210 (179)
Other assets 15,052 (36,691)
Accounts payable, accruals and other liabilities 16,051 28,265
Net cash used in operating activities (6,979,198) (4,837,023)
Investing activities    
Purchases of property, equipment and software (77,115) (70,460)
Capitalized software development costs (7,429) (5,516)
Purchases of available-for-sale investments (634,020) (44,974)
Proceeds from sales of available-for-sale investments 265,634 23,497
Proceeds from maturities and paydowns of available-for-sale investments 87,463 14,327
Changes in loans held for investment, net (97,105) (130,100)
Proceeds from securitization investments 101,292 99,760
Proceeds from non-securitization investments 3,163 0
Purchases of non-securitization investments (45,917) 0
Acquisition of businesses, net of cash acquired (72,301)  
Acquisition of businesses, net of cash acquired   58,540
Net cash used in investing activities (476,335) (54,926)
Financing activities    
Net change in deposits 8,296,657 4,859,240
Net change in debt facilities 902,777 821,096
Proceeds from other debt issuances 339,995 0
Repayment of other debt (595,233) (266,148)
Payment of debt issuance costs (8,078) (4,076)
Taxes paid related to net share settlement of share-based awards (10,660) (7,476)
Proceeds from stock option exercises 1,015 2,489
Payment of redeemable preferred stock dividends (20,047) (20,047)
Finance lease principal payments (380) (364)
Net cash provided by financing activities 8,906,046 5,384,714
Effect of exchange rates on cash and cash equivalents 202 231
Net increase in cash, cash equivalents, restricted cash and restricted cash equivalents 1,450,715 492,996
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period 1,846,302 768,437
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period 3,297,017 1,261,433
Reconciliation to amounts on condensed consolidated balance sheets (as of period end)    
Cash and cash equivalents 2,813,876 935,159
Restricted cash and restricted cash equivalents 483,141 326,274
Total cash, cash equivalents, restricted cash and restricted cash equivalents 3,297,017 1,261,433
Supplemental non-cash investing and financing activities    
Derecognition of securitization investments 5,325 0
Loans held for investment received in acquisition 0 84,485
Available-for-sale securities received in acquisition 0 10,014
Deconsolidation of securitization and residual debt 92,914 0
Deposits credited but not yet received in cash 81,116 14,374
Share-based compensation capitalized related to internally-developed software 22,817 16,177
Deposits assumed in acquisition $ 0 $ 158,016